Lumos Diagnostics Holdings Limited
LDXHF
$0.16
$0.00-0.93%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.75% | -4.60% | 11.40% | 39.94% | 78.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.75% | -4.60% | 11.40% | 39.94% | 78.61% |
| Cost of Revenue | -14.30% | -6.20% | 3.35% | 22.02% | 44.95% |
| Gross Profit | -18.17% | -3.60% | 17.00% | 53.37% | 106.48% |
| SG&A Expenses | 33.22% | 23.84% | 14.05% | 9.26% | 4.46% |
| Depreciation & Amortization | -9.00% | -6.81% | -4.57% | -7.75% | -10.54% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.66% | 12.42% | 8.95% | 9.68% | 10.44% |
| Operating Income | -102.20% | -45.83% | -5.38% | 23.38% | 45.30% |
| Income Before Tax | -85.81% | -21.12% | 16.40% | 30.13% | 43.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -85.81% | -21.12% | 16.40% | 30.13% | 43.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -85.81% | -21.12% | 16.40% | 30.13% | 43.50% |
| EBIT | -102.20% | -45.83% | -5.38% | 23.38% | 45.30% |
| EBITDA | -156.51% | -64.12% | -6.59% | 28.76% | 54.05% |
| EPS Basic | -32.61% | 19.86% | 45.26% | 53.99% | 61.02% |
| Normalized Basic EPS | -35.71% | 19.54% | 45.76% | 62.26% | 72.00% |
| EPS Diluted | -32.61% | 19.86% | 45.26% | 53.99% | 61.02% |
| Normalized Diluted EPS | -35.71% | 19.54% | 45.76% | 62.26% | 72.00% |
| Average Basic Shares Outstanding | 38.81% | 42.49% | 46.85% | 50.57% | 55.48% |
| Average Diluted Shares Outstanding | 38.81% | 42.49% | 46.85% | 50.57% | 55.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |